Escalating Citral Supply Disruption Driving Increased Tightness in Vitamin A & E Markets

Over the past several weeks, global market conditions impacting vitamin A and vitamin E have shifted from early warning signals to active supply disruption. This disruption is closely tied to the availability of Citral, which is a key intermediate in the production of these vitamins.

Based on current developments and historical precedents in similar cycles, we are now entering a phase where supply dislocation—not just price volatility—becomes the defining market dynamic.

Citral, derived from petrochemical inputs, is highly exposed to both energy market instability and geopolitical risk. What we are observing in this Citral supply disruption is a multi-point breakdown across the supply chain, with compounding effects likely in the near term.

Recent Market Developments With The Citral Supply Disruption

Since our last update, several critical signals have emerged:

• Chinese producers are actively withdrawing from spot market participation. A growing number of suppliers are not quoting on new RFQs, indicating tightening internal supply positions.

  
  

• At least one citral producer has declared force majeure. This represents a significant upstream disruption with cascading downstream impacts.

  
  

• Escalating geopolitical tensions in the Gulf region are further increasing risks to energy-derived feedstocks and logistics continuity.

  
  

Supply Chain Implications

These developments are already translating into measurable and accelerating market impacts:

• Rapid tightening of Citral availability. All Citral producers are facing supply issues. With reduced supply, they are motivated to allocate the Citral they can produce to the most profitable markets and applications.

  
  

• Reduced forward visibility on vitamin A & E supply positions.

  
  

• Continued and likely accelerating upward pricing pressure.

  
  

• Increased probability of allocation, delayed fulfillment, or complete lack of spot availability.

  
  

Based on current indicators, we expect further tightening in the coming weeks, particularly as downstream producers begin to fully reflect upstream constraints. In this environment, availability—not price—is quickly becoming the primary risk factor.

What This Means for Procurement and Supply Chain Teams

From a procurement perspective, this is no longer a passive monitoring environment.

We encourage users to:

• Reconfirm supply positions and committed volumes with current vendors.

  
  

• Assess forward coverage vs. potential exposure gaps.

  
  

• Establish or validate secondary sources.

  
  

Historically, in comparable supply cycles, buyers who delayed action faced increased challenges in sourcing limited product, higher pricing, and extended lead times.

Vernon Walden Market Position

At Vernon Walden, we are currently well positioned relative to broader market conditions, supported by:

• Long-term redundant supplier relationships with most worldwide manufacturers and secured, contracted supply.

  
  

• Available inventory aligned with current and anticipated demand.

  
  

• Proactive supply chain planning and market visibility.

  
  

We are actively supporting:

• Expanded requirements from existing customers.

  
  

• Organizations seeking to establish secondary or contingency supply positions.

  
  

Notably, we are seeing a significant increase in inbound inquiries as more companies begin to recognize the shift from stable supply to constrained availability.

Evaluating Supply Options

For companies assessing their exposure, we are available to support with:

• Current pricing and availability assessments.

  
  

• Samples and technical documentation for qualification.

  
  

• Onboarding and approval support.

  
  

Even if your current supply appears stable today, this is a critical window to validate supply security and hedge against near and potential long-term disruption.

For additional information or to discuss your requirements, please contact our team directly.

Conclusion

In conclusion, the current supply disruption of Citral is a significant concern for those involved in the formulation of vitamins A and E. The implications for procurement and supply chain teams are profound. It is essential to act swiftly and decisively to ensure that supply chains remain intact and that product availability is secured.

As we navigate these turbulent times, I encourage you to reach out to us for support. We are here to help you assess your options and ensure that you have the resources you need to succeed.

For further assistance, please feel free to Contact Us.

Contact Us